Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature

被引:0
|
作者
Albarracin, G. [1 ]
Rovira, J. [2 ]
Carreras, L. [3 ]
Rejas, J. [4 ]
机构
[1] Consultora Qualiplus 77 SL, Barcelona 08012, Spain
[2] Univ Barcelona, E-08007 Barcelona, Spain
[3] Soikos SL, Barcelona, Spain
[4] Pfizer SA, Barcelona, Spain
来源
ACTAS ESPANOLAS DE PSIQUIATRIA | 2008年 / 36卷 / 03期
关键词
anxiety disorders; prevalence; therapeutics; cost of illness;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction. The objective is to assess the prevalence and treatment patterns of generalized anxiety disorder (GAD) in Spain as well as the cost associated to this disorder in different countries. Methods. A search in the literature of health and economics databases was conducted. Results. In regards to the 32 references selected, 6 studies had data on the prevalence of GAD and 3 on treatment patterns in Spain and 11 studies on the costs associated to the disease on an international level. The remaining 20 studies were of general interest for methodological or contextual reasons. Conclusions. GAD is a mental disorder with high prevalence. According to some authors, it is probably underdiagnosed. No appropriate long term treatment is available. High health care and social costs are associated to GAD. The frequent presence of comorbidity, different definitions and methodologies used in the studies limits the comparability and synthesis of the results. It also makes it difficult to obtain valid estimations of prevalence and costs.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 50 条
  • [41] Generalized anxiety disorder
    Shinozaki, Gen
    PHARMACOGENOMICS, 2011, 12 (07) : 936 - 936
  • [42] Generalized Anxiety Disorder
    Milz, Helmut
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2010, 53 (01): : 76 - 77
  • [43] Generalized anxiety disorder
    Lavie, CJ
    Milani, RV
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21): : 2239 - 2239
  • [44] Generalized Anxiety Disorder
    不详
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (07) : ITC49 - ITC64
  • [45] Generalized Anxiety Disorder
    White, Henry
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (05): : 563 - 564
  • [46] GENERALIZED ANXIETY DISORDER
    HOEHNSARIC, R
    MCLEOD, DR
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1985, 8 (01) : 73 - 88
  • [47] GENERALIZED ANXIETY AND GENERALIZED ANXIETY DISORDER - DESCRIPTION AND RECONCEPTUALIZATION
    BARLOW, DH
    BLANCHARD, EB
    VERMILYEA, JA
    VERMILYEA, BB
    DINARDO, PA
    AMERICAN JOURNAL OF PSYCHIATRY, 1986, 143 (01): : 40 - 44
  • [48] Neuroimaging in social anxiety disorder: A systematic review of the literature
    Freitas-Ferrari, Maria Cecilia
    Hallak, Jaime E. C.
    Trzesniak, Clarissa
    Santos Filho, Alaor
    Machado-de-Sousa, Joao Paulo
    Chagas, Marcos Hortes N.
    Nardi, Antonio E.
    Crippa, Jose Alexandre S.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (04): : 565 - 580
  • [49] Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature
    Mancini, Michele
    Perna, Giampaolo
    Rossi, Andrea
    Petralia, Antonino
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1167 - 1181
  • [50] Humanistic and economic burden of generalized anxiety disorder in North America and Europe
    Revicki, Dennis A.
    Travers, Karin
    Wyrwich, Kathleen W.
    Svedsater, Henrik
    Locklear, Julie
    Mattera, Maria Stoeckl
    Sheehan, David V.
    Montgomery, Stuart
    JOURNAL OF AFFECTIVE DISORDERS, 2012, 140 (02) : 103 - 112